SCHEMBL4473119

SCHEMBL4473119

Oc1ccc(C(S)c2nc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 11/20 0.65
MAPK13 O15264 10/20 0.65
MAPK12 P53778 10/20 0.65
MAPK11 Q15759 10/20 0.65
GCGR P47871 8/20 0.65
ALOX5 P09917 4/20 0.65
BRAF P15056 3/20 0.65
PRKD3 O94806 2/20 0.65
MAP4K4 O95819 2/20 0.65
FRK P42685 2/20 0.65
MAPK9 P45984 2/20 0.65
CSNK1A1 P48729 2/20 0.65
CSNK1D P48730 2/20 0.65
GSK3B P49841 2/20 0.65
PTK6 Q13882 2/20 0.65
CLK4 Q9HAZ1 2/20 0.65
RAF1 P04049 2/20 0.65
KDM4E B2RXH2 1/20 0.65
CIT O14578 1/20 0.65
GAK O14976 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6107665 0.86 MAPK14 (0.54) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL6601709 0.82 MAPK14 (0.60) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL8113784 0.82 MAPK14 (0.60) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL4466769 0.81 ALOX5 (0.61) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL1387734 0.80 MAPK14 (0.67) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL9646788 0.80 MAPK14 (0.67) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL4460361 0.80 MAPK14 (0.51) MAPK14MAPK13MAPK12MAPK11GCGR
Sb-202190 SCHEMBL158854 0.79 MAPK13 (1.00) MAPK14MAPK13MAPK12MAPK11GCGR
Sb-202190 SCHEMBL3386753 0.79 MAPK13 (1.00) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL9195650 0.79 MAPK13 (1.00) MAPK14MAPK13MAPK12MAPK11GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582660-B2 2-thio-substituted imidazole derivatives and their use in pharmaceutics C-A-I-R BIOSCIENCES GMBH (DE) 2009-09-01 US disclosed
US-20060235054-A1 2-Thio-substituted imidazole derivatives and their use in pharmaceutics MERCKLE-GMBH (DE) 2006-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235054-A1 2-Thio-substituted imidazole derivatives and their use in pharmaceutics IL2, TPMT, IFNG MAPK14 3841/4885MAPK13 3803/4885MAPK12 3533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.